Fundamental dimension Equity attribute | ACHCPeer $31.51▼-1.16% Cap $2.93BP/E -2.5x QuantScore44/100 | LFSTLeader $12.93▲+2.95% Cap $4.94BP/E 99.3x QuantScore67/100 | UHSPeer $186.89▼-0.66% Cap $11.01BP/E 7.6x QuantScore65/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
95/100 |
93/100 |
87/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 57/100 | 99/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 66/100 | 56/100 |
Growth Revenue / earnings growth & margins | 19/100 | 59/100 | 51/100 |
Sentiment Analyst ratings, targets & revisions | 51/100 | 58/100 | 30/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.5x | 99.3x | 7.6x |
Forward P/E (next FY) | 20.6x | 80.5x | 8.3x |
EV / EBITDA (TTM) | -7.8x | 37.3x | 5.7x |
Price / Sales | 0.9x | 3.1x | 0.6x |
Price / Free Cash Flow | -155.1x | 23.5x | 13.3x |
PEG ratio | 0.00 | 0.04 | 0.27 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 8 / 9 | 8 / 9 |
Altman Z-Score | 0.49 (Distress) | 4.61 (Safe) | 3.14 (Safe) |
Total debt / equity | 1.30 | 0.14 | 0.70 |
Quick ratio | 1.6x | 1.4x | 1.0x |
Interest coverage | 2.2x | 7.8x | 13.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +5.0% | +13.9% | +9.7% |
Net income growth YoY | -531.4% | +116.8% | +30.4% |
Gross margin (TTM) | 35.6% | 33.6% | 90.7% |
Operating margin (FY) | 11.7% | 1.7% | 11.5% |
FCF margin (FY) | -13.3% | 7.7% | 4.9% |
5. Trailing price performancePrice change over period |
1M return | +13.3% | +9.6% | +5.6% |
3M return | -8.7% | +18.6% | +20.0% |
6M return | +15.1% | +83.4% | +7.2% |
Year to date | +122.1% | +83.7% | -14.3% |
1Y return | +34.7% | +148.7% | -11.3% |
3Y return | -58.0% | +128.8% | +50.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-117.06 -471.5% premium | $17.13 +32.5% upside | $297.20 +59.0% upside |
Wall Street consensus target | $34.78 +10.4% · range $30.00–$40.00 | $14.14 +9.4% · range $9.00–$19.00 | $193.00 +3.3% · range $166.00–$290.00 |
Consensus stance | 68% Buy28% Hold4% Sell | 82% Buy18% Hold-0% Sell | 39% Buy57% Hold5% Sell |